Evidence map›Paper›PMID 30186565›Full record

ArticleIranian journal of basic medical sciences2018

Cytotoxic effect of pyocyanin on human pancreatic cancer cell line (Panc-1).

Aylin Moayedi, Jamileh Nowroozi, Abbas Akhavan Sepahy

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. AvirulentmicroLife · 2025
    Article
  5. mSphere · 2024
    Article
  6. Pigments from pathogenic bacteria: a comprehensive update on recent advances.World journal of microbiology & biotechnology · 2024
    Review
  7. Article
  8. Review
  9. bioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. The two faces of pyocyanin - why and how to steer its production?World journal of microbiology & biotechnology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Quorum Sensing Inhibitors to QuenchPharmaceuticals (Basel, Switzerland) · 2021
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aylin MoayediDepartment of Microbiology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Jamileh NowrooziDepartment of Microbiology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Abbas Akhavan SepahyDepartment of Microbiology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Islamic Azad University North Tehran Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPyocyanin, a blue-green pigment produced by MATERIALS AND

methodsPolymerase Chain Reaction (PCR) was applied to confirm the existence of a specific pyocyanin producing gene (phzM). The pigment was then characterized by UV-visible, FT-IR, and HPLC analysis. Panc-1 cells were treated by different concentrations of pyocyanin and their cytotoxic effect as well as the induction of apoptosis/necrosis were evaluated by XTT assay and flow cytometry.

resultsAn overnight pyocyanin treatment resulted in significant cell reduction in a concentration-dependent manner. Inhibition rate of 6 mg.ml-1 pyocyanin (the highest concentration) extracted from clinical and soil isolates of

conclusionWe reported, for the first time, cytotoxic effects of pyocyanin against human pancreatic cancer cell line. Considering this effect of the pigment, study on pyocyanin as a potential anti-tumor biodrug requires further studies.

Indexed as

ApoptosisCytotoxicPanc-1Pancreatic cancerPseudomonas aeruginosaPyocyanin

Identifiers

PMID30186565
PMCPMC6118082
OpenAlexW2889653001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.